Award
Delivery Order #80JSC026FA108
Innovative Cartilage Tissue Construct Development Contract for NASA by STI Legacy, Inc.
Buyer
National Aeronautics and Space Administration
Award Amount
$650,000.00
Ceiling
$650,000.00
Awarded
October 31, 2028
Period of Performance
Oct 31, 2028 – Oct 31, 2028
Identifier
80JSC026FA108
NAICS
541714
This delivery order contract was recently awarded under a significant indefinite delivery/indefinite quantity (IDIQ) vehicle to STI Legacy, Inc., a small U.S.-owned business specializing in manufacturing and research and development products. The contract focuses on developing a cartilage tissue construct with immunomodulatory properties designed to maintain healthy cartilage cell function in challenging environments such as inflammation and immune activation both on Earth and in space. This work supports NASA's broader mission of advancing scientific knowledge and capabilities in microgravity and related fields. The scope includes the design and development of advanced tissue constructs capable of enduring environmental stresses encountered in space exploration. The contract is linked to a parent IDIQ contract awarded competitively to STI Legacy, demonstrating ongoing trusted collaboration with NASA. The performance will take place in Lexington, Kentucky, with a multi-year timeline implied by the stated execution period. This award underscores the importance of biotechnology innovations for space and terrestrial health applications, bridging cutting-edge science with NASA’s exploration goals.
Description
DEVELOP A CARTILAGE TISSUE CONSTRUCT WITH IMMUNOMODULATORY PROPERTIES CAPABLE OF MAINTAINING HEALTHY CARTILAGE CELL FUNCTION UNDER CHALLENGING ENVIRONMENTS, SUCH AS INFLAMMATION AND ACTIVATED IMMUNE CELLS, BOTH ON EARTH AND IN SPACE.